Day2~5: 2 tablets (0.1g/table), BID
Sponsors
Peking University Third Hospital
Conditions
Novel Coronavirus Pneumonia (COVID-19)
Phase 4
Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial
RecruitingChiCTR2000029898
Start: 2020-02-17Updated: 2020-03-02
Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial
RecruitingChiCTR2000029899
Start: 2020-02-17Updated: 2020-03-02